Bactiguard enters new partnership for South Africa

Bactiguard has entered partnership with Surgical Innovations Pty Ltd (“SI”), a company within the Medical arm of Ascendis Health, the JNB listed healthcare giant and leading supplier to the healthcare sector in South Africa. 

“Surgical Innovations is a leading provider of medical devices to both public and private hospitals, representing some of the most recognized international brands. As part of the Ascendis group they have an unsurpassed access to healthcare providers and in-depth understanding of how to address the South African market”, says Christian Kinch, CEO,Bactiguard.

“We have been looking for a strong distributor for South Africa for a long time, and have now finally found a partner that matches our requirements, both in their growth ambitions and company culture. I am truly excited to start this collaboration with Surgical Innovations”, Christian Kinch continues.

The Middle East and Africa has been an important region since the commercial launch of the Bactiguard Infection Protection portfolio of products. We are already present in all the major markets in the Middle East, and now we are increasing our footprint by adding the most important African market. South Africa often serves as an entry point to the entire continent, having the most developed health care and being a reference for other countries. An earlier attempt to enter South Africa was made, but was interrupted before the registration of the products were completed. The registration process, expected to take 6-12 months, will now been initiated by Surgical Innovations.

“We are immensely proud and excited about this partnership” says Tony Lowther, MD of Ascendis Medical. “It is our constant mission and duty to find world class technologies, products and innovation and bring them directly to our patients and customers in South Africa where we can enhance and positively impact the quality of healthcare delivery for all in our country. These products specifically will directly target increasing infection rates; they will make our hospitals safer places and therefore improve patient outcomes significantly – and nothing is more important to us than that”. 

Ascendis Health is a South African-based health and care company with an impressive portfolio of market leading brands, delivering diverse solutions and services to people, plants and animals. The company was founded in 2008 by Coast2Coast Capital and has been listed on the Johannesburg Stock Exchange since 2013.

For further information, please contact:

Nina Nilsson, SVP Sales and Marketing, mobile: +46 702 14 87 49

About Bactiguard

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large.

The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.

Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 60 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.

Read more about how Bactiguard saves lives on


About Us

Bactiguard is a Swedish medtech company with a global presence, offering a solution that prevents healthcare associated infections caused by medical devices. By preventing infections, we contribute to a reduced use of antibiotics and the spread of multi-resistant bacteria, which is a growing problem worldwide. We save lives, increase patient safety and significantly reduce the cost for the healthcare and society. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevents bacterial growth. The coating can be applied on almost all medical devices. Bactiguard-coated urinary catheters are market leading in the US and Japan and the company has also its own product portfolio consisting of foley catheters, central venous catheters and endotrachealtubes. Bactiguard is a growth company, focused on markets in Europe, Middle East, Asia and Latin America. The company has about 70 employees worldwide, mainly at the headquarters in Stockholm and the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more about Bactiguard at